Valuation: Maravai LifeSciences Holdings, Inc.

Market Cap 1.07B 933M 861M 794M 1.5B 103B 1.53B 10.29B 4.05B 50.37B 4.01B 3.92B 173B P/E 2026 *
-23.4x
P/E 2027 * -31.1x
Enterprise Value 1.08B 945M 872M 804M 1.52B 104B 1.55B 10.42B 4.1B 51B 4.06B 3.97B 176B EV / Sales 2026 *
5.14x
EV / Sales 2027 * 4.58x
Free-Float
41.44%
Yield 2026 *
-
Yield 2027 * -
1 day+2.12%
1 week+18.88%
Current month+16.03%
1 month+39.23%
3 months+113.57%
6 months+84.69%
Current year+122.77%
1 week 6.33
Extreme 6.33
7.26
1 month 5.09
Extreme 5.09
7.26
Current year 2.8
Extreme 2.8
7.26
1 year 1.99
Extreme 1.99
7.26
3 years 1.66
Extreme 1.665
12.92
5 years 1.66
Extreme 1.665
63.55
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
7/8/26 Tax

Chief Executive Officer

-29,250 0.0198%
6/30/26 Tax

Chief Financial Officer

-65,584 0.0445%
6/10/26 Sell

General Counsel

-25,000 0.0169%
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%+18.88%+197.94%-42.31% 1.07B
-0.15%+3.79%+151.51%+101.95% 4.72B
+3.71%+8.83%+120.60%+195.74% 3.67B
+7.30%+18.20%+124.22%-35.90% 2.23B
-1.51%+39.35%+233.45%+286.48% 2.05B
-5.50%-0.75%-29.67%-37.57% 2.04B
-2.39%-1.55%-10.78%+34.35% 875M
-4.16%+6.17%-34.21%-11.42% 513M
-3.06%-3.18%-3.97% - 476M
-8.02%-9.23% - - 179M
Average -1.17%+8.20%+83.23%+61.41% 1.78B
Weighted average by Cap. +0.56%+10.56%+115.42%+93.78%

Financials

2026 *2027 *
Net sales 210M 184M 170M 156M 295M 20.26B 301M 2.03B 798M 9.92B 790M 773M 34.17B 226M 197M 182M 168M 316M 21.75B 323M 2.18B 856M 10.65B 848M 830M 36.67B
Net income -39.2M -34.25M -31.61M -29.13M -54.91M -3.77B -56.13M -378M -149M -1.85B -147M -144M -6.36B -28.2M -24.64M -22.74M -20.96M -39.51M -2.72B -40.38M -272M -107M -1.33B -106M -104M -4.58B
Net Debt 13.46M 11.76M 10.85M 10M 18.85M 1.3B 19.27M 130M 51.01M 635M 50.54M 49.43M 2.18B -33.46M -29.24M -26.99M -24.87M -46.88M -3.22B -47.92M -323M -127M -1.58B -126M -123M -5.43B
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
416
Date Price Change Volume
26-07-17 US$7.240 +2.12% 2,845,187
26-07-16 US$7.090 +0.71% 5,237,987
26-07-15 US$7.040 +8.14% 4,808,483
26-07-14 US$6.510 +2.36% 6,440,545
26-07-13 US$6.360 +4.43% 3,145,942
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
7.240USD
Average target price
5.900USD
Spread / Average Target
-18.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock